AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) sold $1K-$15K of Nektar Therapeutics (NKTR) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a sale of Nektar Therapeutics (NKTR) stock worth $1K-$15K in a STOCK Act filing on Oct 2, 2018.
The trade happened on Jun 21, 2018, 103 days before it was made public.
NKTR has moved -94.8% since the trade date, from $837.90 to $43.58 (Oct 2, 2026 close).
- Traded
- Jun 21, 2018
- Disclosed
- Oct 2, 2018
- Filing delay
- 103 days
- Price since
- -94.8%
- Source
- STOCK Act disclosure
Other trades in this disclosure (60)
- BuyAAPL$1K-$15KOct 2, 2018
- BuyABEV$1K-$15KOct 2, 2018
- BuyABMD$1K-$15KOct 2, 2018
- SellADBE$1K-$15KOct 2, 2018
- SellADBE$1K-$15KOct 2, 2018
- BuyAIR$1K-$15KOct 2, 2018
- BuyALGT$1K-$15KOct 2, 2018
- BuyALNY$1K-$15KOct 2, 2018
- BuyCENT$1K-$15KOct 2, 2018
- BuyCGNX$1K-$15KOct 2, 2018
- BuyCSGP$1K-$15KOct 2, 2018
- BuyFET$1K-$15KOct 2, 2018
- SellGIS$1K-$15KOct 2, 2018
- SellGIS$1K-$15KOct 2, 2018
- SellGIS$1K-$15KOct 2, 2018
- BuyGIS$1K-$15KOct 2, 2018
- SellGOOG$1K-$15KOct 2, 2018
- SellGOOG$1K-$15KOct 2, 2018
- SellHEI$1K-$15KOct 2, 2018
- SellHUM$1K-$15KOct 2, 2018
More NKTR insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.